Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 5.1 Exhibit 5.1
- 8.1 Exhibit 8.1
- 23.3 Exhibit 23.3
- 23.4 Exhibit 23.4
- 23.5 Exhibit 23.5
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- 99.11 Exhibit 99.11
- Download Excel data file
- View Excel data file
Associated filings
- 14 Apr 21 EFFECT Notice of effectiveness
- 13 Apr 21 424B3 Prospectus supplement
-
9 Apr 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Mar 21 S-4 Registration of securities issued in business combination transactions
RSLS similar filings
Filing view
External links
Exhibit 23.5
Consent of Independent Registered Public Accounting Firm
ReShape Lifesciences Inc.
San Clemente, California
We hereby consent to the use in the joint proxy statement/prospectus constituting a part of this Registration Statement of our report dated March 10, 2021, relating to the consolidated financial statements of ReShape Lifesciences Inc., which is contained in that joint proxy statement/prospectus.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Costa Mesa, California
April 9, 2021